About webmaster-prism

This author has not yet filled in any details.
So far webmaster-prism has created 98 blog entries.

How to Maximize Pharmacy Availability of Prescription Medicine

2021-10-19T20:42:30+00:00October 19th, 2021|Categories: Blog|

In a world with ever changing needs and demands, especially amongst a global pandemic, issues with the availability of prescription medications continue to challenge the industry. The last words you want to hear as a patient, pharmacist, or sales representative are “out of stock”. The following tips and best practices can help reduce the chances of an issue to begin with: It starts with [...]

Comments Off on How to Maximize Pharmacy Availability of Prescription Medicine

Adding State Licensing to Your Cell and Gene Launch Strategy

2021-07-06T14:21:39+00:00July 16th, 2021|Categories: News|

The main question that sits at the center of the most common licensing questions and obstacles for cell and gene strategies: how do companies license a product that is often never touched by the parties that need to hold the license? Ryan Fields, Sr. Vice President of Regulatory Services at Two Labs answers this question and more in his article featured on Pharmaceutical Outsourcing. Read more here.

Comments Off on Adding State Licensing to Your Cell and Gene Launch Strategy

New White Paper: Healthcare Policy Initiatives – Is Change Coming?

2021-07-13T19:42:14+00:00July 13th, 2021|Categories: Blog|

The high cost of drugs has become a bipartisan discussion among representatives in Washington, DC. Both the Trump and Biden administrations have taken actions to reduce healthcare spending, and particularly have focused on prescription drug spending. In order to better understand these recent policies and their expected impact on US healthcare payers and manufacturers, Two Labs conducted a panel event with Medical Directors and Pharmacy Directors from managed [...]

Comments Off on New White Paper: Healthcare Policy Initiatives – Is Change Coming?

Two Labs, an Envision Pharma Group company Acquires Riparian

2021-07-06T13:52:51+00:00July 7th, 2021|Categories: News|

The partnership expands Two Labs’ suite of services and broadens its integration competency to include government price reporting COLUMBUS, Ohio (7/7/2021) -- Two Labs, an industry-leading pharma services company and part of Envision Pharma Group, today announced that it has acquired Riparian, a pharma consulting and SaaS company that helps manufacturers navigate pricing regulations, reporting, strategies, and program operations. The acquisition expands Two Labs’ suite of pharma services, allowing the [...]

Comments Off on Two Labs, an Envision Pharma Group company Acquires Riparian

US Value-Based Management of Oncology Drugs: An Explorative Study of Payer and Provider Tools to Manage the Rising Spending on Oncology Drugs

2021-07-02T14:11:46+00:00July 2nd, 2021|Categories: News|

Oncology and other specialty therapies continue to get more and more expensive for payers, placing immense financial pressure on the HCP. The percentage increase in worldwide spending on oncology medications went up by double digits every year between 2013 and 2018, and reached nearly $150 billion in 2018. Modern cancer therapies significantly improve disease outlook, but with a tremendous cost of treatment. Read more from Two Lab’s Senior Consultant Anne [...]

Comments Off on US Value-Based Management of Oncology Drugs: An Explorative Study of Payer and Provider Tools to Manage the Rising Spending on Oncology Drugs

Envision Pharma Group and Portfolio Company Two Labs Pharma Services Launch MSL Solutions

2021-06-28T03:16:51+00:00June 28th, 2021|Categories: News|

With the new offering, Envision and Two Labs are poised to deliver more options and innovation to the Medical Science Liaison (MSL) Space. Two Labs Pharma Services and its parent company Envision Pharma Group – organizations that are deeply engaged in providing Medical Affairs services to biopharmaceutical companies – are proud to announce an exciting new, combined offering: MSL Solutions. Designed to grow and enhance both organizations’ ability to deliver [...]

Comments Off on Envision Pharma Group and Portfolio Company Two Labs Pharma Services Launch MSL Solutions

Managing Inventory in an Inventory Optimization World

2021-06-02T16:04:17+00:00May 27th, 2021|Categories: Blog|

Across the board, wholesalers are moving toward inventory optimization – and that makes sense. They’re holding just enough inventory to match demand projections, opting to stay lean and efficient. But while this is the right move for their business, any type of aberration that impacts shipping or demand can cause some serious heartburn for manufacturers, ultimately affecting pharmacies’ abilities to stock product.  It’s up to manufacturers to understand how [...]

Comments Off on Managing Inventory in an Inventory Optimization World

How Do You Know If Your Medical Device Needs State Licensing?

2021-04-28T18:42:12+00:00April 28th, 2021|Categories: Blog|

The medical device industry is growing, and we’re seeing the impact at Two Labs as more and more clients are asking us for support in launching their new medical device products. The medical device industry is projected to grow 6.8% through 2025. One area of planning that these clients are seeking advice on is state licensing. While the state licensing process for a typical new drug launch may be [...]

Comments Off on How Do You Know If Your Medical Device Needs State Licensing?

Mapping the Prescriber Journey: Are you overlooking this key launch planning step?

2021-04-26T14:51:53+00:00March 31st, 2021|Categories: Blog|

During launch planning, many manufacturers place a great deal of emphasis on mapping and understanding the patient journey – and for good reason. The better you understand the patient journey, the better your ability to create a positive patient experience, leading to improved adoption and adherence rates. But while this is important, there’s an equally vital component of the launch strategy that often gets overlooked: mapping the prescriber journey. [...]

Comments Off on Mapping the Prescriber Journey: Are you overlooking this key launch planning step?

5 Ways Compendia Impacts Your Business

2021-03-16T20:00:09+00:00March 16th, 2021|Categories: Blog|

Most manufacturers consider Compendia “price books,” but while pricing is part of Compendia, it’s actually just a small component. Much of the information coming from Compendia is clinical and has an impact on every part of the product decision making process. Unfortunately, most manufacturers don’t fully understand the effect Compendia data has on their launch strategy until something goes wrong. We’ve identified 5 of the biggest ways Compendia [...]

Comments Off on 5 Ways Compendia Impacts Your Business
Go to Top